Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Neuroendocrine Tumors 2Vaginal Neoplasms 1Lymphoma, Follicular 1Glioblastoma 1Endometrial Serous Adenocarcinoma 1Astrocytoma 1

Interventions

Specimen Handling 7Cisplatin 7pembrolizumab 6Nivolumab 4Magnetic Resonance Spectroscopy 4Human Papillomavirus DNA Tests 4Fulvestrant 4Colposcopy 4Paclitaxel 3Carboplatin 3Bevacizumab 3palbociclib 2lenvatinib 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Platinum 2Magnetic Resonance Imaging 2Gemcitabine 2Fluorodeoxyglucose F18 2Drug Therapy 2Congresses as Topic 2Brachytherapy 2Biopsy 2Axitinib 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 21,2-diaminocyclohexaneplatinum II citrate 2ulixertinib 1trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × 30 days × Clear all
NCT02466971 2026-05-29

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02595879 2026-05-29

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled 22 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡